Can Vertex Make Billions With a New Game-Changing Treatment? The Answer May Be Just AheadThe Motley Fool • 11/05/21
Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/03/21
Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/02/21
Why Earnings Season Could Be Great for Vertex Pharmaceuticals (VRTX)Zacks Investment Research • 10/29/21
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 10/26/21
Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for Serious DiseasesBusiness Wire • 10/26/21
Can Vertex (VRTX) Climb 42% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 10/21/21